Cervical cancer is one of the common malignant tumors of the female reproductive system. The age of onset is mostly 40-60 years old. Fifty years ago, cervical cancer was the leading cause of female tumor deaths. Due to the promotion and popularization of cervical exfoliative cytology examination, many precancerous lesions and early-stage cancers have been prevented and treated at an early stage, advanced-stage cancers have been significantly reduced compared with the past, and the five-year survival rate and the cure rate have been improved significantly. Early cervical cancer often has no obvious symptoms and is easily neglected by clinics. The main symptoms of cervical cancer are vaginal bleeding and increased leukorrhea, and a series of clinical symptoms appear in late-stage patients according to the scope of spread of lesions and invaded organs; cervical cytological examination is the most effective method to detect early cervical cancer at present. Therefore, for suspected cervical cancer or in order to exclude cervical cancer, this examination should be applied to all married women who visit outpatient clinics in order to detect cervical cancer at an early stage. Biopsy is the most important basis for diagnosing cervical cancer. The main treatments for cervical cancer are surgery and radiation therapy. Most experts are in favor of adopting surgery for early-stage cases such as Stage I and Stage IIA, and adopting radiotherapy for Stage IIA and above. The effect of radiotherapy in early stage cases is almost the same as that of surgery, and radiotherapy in advanced stage cases has more advantages than surgery. The advantage of radiotherapy is that it is applicable to all patients, while surgery requires certain indications. Chemotherapy is an effective complement to surgery and radiotherapy and is mainly used in patients with advanced recurrent metastases.